SEMA4D and arthritic joint disease: Moreover, Sema4D induces the production of inflammatory mediators by RA monocytes, while the administration of an anti-Sema4D antibody reduces the arthritis severity and inflammatory cytokines in the Collagen Induced Arthritis (CIA) mouse model [7].